GYRE THERAPEUTICS, INC.
GYRE THERAPEUTICS, INC. (GYRE) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 10 transactions totaling $950.8K, demonstrating a bearish sentiment with -$950.8K in net insider flow. The most recent transaction on May 1, 2024 involved a transaction of 20,000 shares valued at $138.6K.
GYRE Insider Activity Summary
Who Is Buying GYRE Stock?
No significant insider buying has been recorded for GYRE in the recent period.
Who Is Selling GYRE Stock?
No significant insider selling has been recorded for GYRE in the recent period.
Is GYRE THERAPEUTICS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for GYRE is bearish with an Insider Alignment Score of 0/100 and a net flow of -$950.8K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
GYRE Frequently Asked Questions
Understanding GYRE Insider Activity
Insider trading at GYRE THERAPEUTICS, INC. (GYRE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading GYRE stock, having executed 10 transactions in the past 90 days. The most active insider is Nassim Usman (Executive), who has made 8 transactions totaling $1.4M.
Related Tools
Track GYRE THERAPEUTICS, INC. Insider Activity
Get notified when executives and directors at GYRE file new Form 4 transactions